 |
| (AS OF 12/31/2009) |
Ticker EHK (NYSE) |
|
Gross expense ratio: 1.20% |
|
Net expense ratio: .85%* |
|
Inception date: n/a |
|
The Fund is new and has no operating or performance history.
|
|
 |
|
| (AS OF 12/31/2009) | |
Number of holdings:
30 |
|
Full Market Cap:
$72.6B |
|
Median Market Cap:
$1.0B |
|
Trailing P/E:
28.48 |
|
Projected P/E:
19.93 |
|
P/B:
4.54 |
|
P/Sales:
2.98 |
|
P/Cash flow:
18.25 |
 |
| Holdings are subject to change (AS OF 12/31/2009) |
 |
| Company | Weight |
| CIPLA Ltd | 9.48% |
| Sun Pharmaceutical Industries Ltd | 9.02% |
| Gedeon Richter Nyrt | 8.29% |
| Aspen Pharmacare Holdings Ltd | 7.79% |
| Dr.Reddy’s Laboratories | 7.20% |
| Mindray Medical International Ltd | 6.67% |
| Netcare Ltd | 5.55% |
| Ranbaxy Laboratories | 4.40% |
| Lupin Ltd | 3.97% |
| Pharmstandard | 3.90% |
 |
| (AS OF 12/31/2009) |
 |
| Country | Weight |
| India | 42.31% |
| South Africa | 19.34% |
| China Offshore | 13.57% |
| Hungary | 9.28% |
| Brazil | 5.76% |
| Russia | 3.90% |
| Indonesia | 1.51% |
| Malaysia | 1.41% |
| Thailand | 1.29% |
| Poland | .72% |
| Turkey | .71% |
| Kuwait | .19% |
*This agreement will remain in effect and will be contractually binding at least until May, 18 2009.
Investors should carefully consider the investment objectives, risks, charges and expenses of the Funds before investing. To obtain a prospectus containing this and other important information, please call 1-888-800-4EGS (4347) or click here to view or download a prospectus online. Read the prospectus carefully before you invest. There are risks involved with investing including the possible loss of principal. Past performance does not guarantee future results.
Emerging market investments involve risk of capital loss from unfavorable fluctuation in currency values, from differences in generally accepted accounting principles, from economic or political instability in other nations or increased volatility and lower trading volume. This fund will concentrate its investments in issuers of one or more particular industries to the same extent that its Underlying Index is so concentrated and to the extent permitted by applicable regulatory guidance. Concentration risk results from maintaining exposure to issuers conducting business in a specific industry.
Emerging Global Shares are distributed by ALPS Distributors Inc.
Download EHK Fact Sheet